Marketing Approval for Zetiq’s CellDetect® in China

Bio-Light announced that the product CellDetect®, manufactured by Zetiq – a subsidiary under the full control of Micromedic, designed to diagnose cancerous cells in the cervix, has been approved by the State Food and Drug Administration (SFDA) of the People’s Republic of China for marketing in China.

Link to the complete article

Link to Newsroom

Comments are closed.